×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Congress 2021
Final Programme PDF
Advanced Search
16.09.2021
17.09.2021
18.09.2021
19.09.2021
20.09.2021
21.09.2021
22.09.2021
Educational session
Expert selection
Multidisciplinary session
On-demand session
Special Symposium
ePoster
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
On-demand
08:30(1h 10m)
Educational sessions on-demand
16:30(1h 10m)
Multidisciplinary sessions on-demand
12:30(1h 10m)
Special Symposia on-demand
10:00(1h)
Test Session for automatic upload
On-demand Educational sessions
08:30(1h 05m)
Beating cancer at the EU level: Influential policies changing the paradigm of the cancer (treatment) lifecycle
08:30(50m)
Brain metastases: Treatment and controversies
08:30(50m)
Cervical cancer: From prevention to innovative therapies
08:30(50m)
Clinical and translational insights from the genomics of gastric cancers
08:30(50m)
Complementary therapies and cannabinoids: Evidence is gathering
08:30(50m)
Convergence of advanced computation and big data to accelerate precision cancer medicine
08:30(50m)
Earlier treatment in prostate cancer: How can we maximize the therapeutic index?
08:30(50m)
Emerging therapeutic concepts and molecules
08:30(50m)
Gut microbiome in the immunotherapy arena from biomarker to therapeutics
08:30(50m)
How does real-world evidence inform decision making for new drug funding?
08:30(50m)
Improving outcomes in bladder cancer: New treatment and novel approaches
08:30(50m)
Innovations in diagnostics for precision medicine
08:30(50m)
Lung cancer screening in 2021
08:30(50m)
Management of patients with metastatic breast cancer
08:30(50m)
New kids on the block in early breast cancer treatment
08:30(50m)
New standards of care in sarcomas in 2021
08:30(50m)
News and strategies in multiple myeloma
08:30(50m)
Precision cancer medicine through multidimensional tumor characterisation
08:30(50m)
Prevention strategies
08:30(50m)
Realising potential combination and personalised therapy
08:30(50m)
Refining the use of immune-checkpoint inhibition
08:30(50m)
State-of-the-art in the treatment of advanced endocrine neoplasms
08:30(50m)
Synthetic immune therapy
08:30(50m)
Testing for fusions: When and how?
08:30(50m)
The emerging role of immunotherapy in the curative setting
08:30(50m)
The year in review of molecularly driven NSCLC
08:30(50m)
What is the optimal continuum of care in 2021 in colorectal cancer?
On-demand ePoster
08:00(10h)
ePoster Display
On-demand Multidisciplinary sessions
16:30(1h 05m)
A multidisciplinary approach to early endometrial cancer
16:30(1h 05m)
Bedside to bench: Management of acquired resistance
16:30(50m)
Biology-guided combination cancer therapy
16:30(50m)
Dilemmas in the management of T-cell lymphomas
16:30(50m)
Integration of patient-reported symptoms into cancer care
16:30(1h 05m)
Liver cancer: Benefitting from increasing choices of treatment option
16:30(1h 05m)
Management of a clinically challenging patient with clear cell RCC
16:30(50m)
Management of gastroenteropancreatic neuroendocrine carcinoma
16:30(50m)
Managing a challenging situation in metastatic breast cancer patients treated with immunotherapy
16:30(50m)
Neoadjuvant and adjuvant strategies in melanoma
16:30(50m)
Neurological complications of cancer treatment
16:30(50m)
Node-positive locally advanced prostate cancer
16:30(50m)
Novel aspects of small cell lung cancer biology and treatment
16:30(50m)
NSCLC: The data don’t exactly address this, but…
16:30(50m)
Oligometastatic colorectal cancer: Don’t miss the boat
16:30(50m)
Retroperitoneal sarcoma
16:30(50m)
Successful strategies for tumour agnostic treatment approaches
16:30(55m)
Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
16:30(1h 10m)
When and how should age influence treatment
On-demand Special Symposia
12:30(1h 05m)
Adjuvant treatment for colon cancer
12:30(1h 05m)
Biomarkers in head and neck cancer
12:30(1h 05m)
Exploring avenues for immunotherapy in sarcoma
12:30(1h 05m)
Fast-track prostate cancer precision medicine development: Tools and caveats
12:30(1h 10m)
Impact of breast cancer biology in the neoadjuvant setting
12:30(1h 05m)
Impact of lineage plasticity and heterogeneity on cancer therapies
12:30(1h 05m)
Innovative approaches in neuro-oncology
12:30(1h 05m)
Is the concept of personalised medicine applicable to non-colorectal gastro-intestinal cancer?
12:30(1h 20m)
Know your immunotherapy and its toxicities
12:30(1h 05m)
Long-term side effects in the treatment of lymphoma
12:30(1h 05m)
Molecular-driven therapy in ovarian cancer
12:30(1h 05m)
Neoadjuvant immunotherapy of NSCLC
12:30(1h 05m)
New protein-based therapeutics
12:30(1h 05m)
Next frontiers or new players in immuno-oncology
12:30(1h 05m)
Next generation therapies in metastatic breast cancer
12:30(1h 05m)
Personalised therapy in bladder and renal cancer
12:30(1h 05m)
Ready for 2022 and beyond: Building on recent advances in neuroendocrine neoplasms (NENs)
12:30(50m)
Rising stars: PIs of today and tomorrow
12:30(1h 05m)
Strategies to tackle resistance to checkpoint blockade
12:30(1h 05m)
Targeting KRAS in lung cancer: Progress and next steps
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events